Carticel (autologous cultured chondrocyte) implantation
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
18
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Articular Cartilage
Conditions
Articular Cartilage, Cartilage Diseases
Trial Timeline
Mar 1, 1995 → Jan 1, 2009
NCT ID
NCT00140634About Carticel (autologous cultured chondrocyte) implantation
Carticel (autologous cultured chondrocyte) implantation is a pre-clinical stage product being developed by Vericel for Articular Cartilage. The current trial status is completed. This product is registered under clinical trial identifier NCT00140634. Target conditions include Articular Cartilage, Cartilage Diseases.
Hype Score Breakdown
Clinical
5
Activity
2
Company
5
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00158613 | Approved | Completed |
| NCT00140634 | Pre-clinical | Completed |
Competing Products
6 competing products in Articular Cartilage
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| MRA(Tocilizumab) | Chugai Pharmaceutical | Phase 3 | 77 |
| Abatacept | Bristol Myers Squibb | Phase 3 | 76 |
| Certolizumab Pegol (CZP) + Certolizumab Pegol (CZP) | UCB | Phase 3 | 74 |
| autologous cultured chondrocytes on porcine collagen membrane | Vericel | Phase 3 | 72 |
| autologous cultured chondrocytes on porcine collagen membrane | Vericel | Pre-clinical | 18 |
| Carticel (autologous cultured chondrocyte) implantation | Vericel | Approved | 80 |